【発明の名称】ベンゾジアゼピン化合物を用いる新規治療法

Japanese Patent JP3015129

B2

The invention relates to the use of a benzodiazepine compound having the formula wherein R<3> is hydrogen, C1-8-alkyl which may be branched, or cycloalkylmethyl; R<7> and R<8> are independently hydrogen, halogen, CF3, CN, NO2, NH2, C1-4-alkyl or C1-4-alkoxy; and R<4> is hydrogen and R<5> is hydrogen or C1-7-alkyl; or R<4> and R<5> together signify (CH2)n wherein n is an integer of 2-3, as the active ingredient for preparing a pharmaceutical composition for treating a central nervous system disorder related to the excitatory amino acids.

WO/2021/224867	PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND NAZARTINIB
WO/2008/106131	COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS
JP2000516204	INDUSTRIAL APPLICABILITY [Title of Invention] Useful formulation of acid addition salt chemicals

Life Hert Jensen
Jörgen Dreiel
Frank weten

JP7990091A

March 06, 2000

April 12, 1991

Click for automatic bibliography generation  

Nyurocer Achi Actiesel Scab

A61K31/55; A61P9/10; A61P25/04; A61P25/06; A61P25/18; A61P25/28; C07D487/04; (IPC1-7): A61K31/5517; A61P9/10; A61P25/06; A61P25/18

Mitsufumi Esaki (2 others)

Previous Patent: 撮影装置

Next Patent: 表面平滑性の良好な皮革様シート状物の製造法